Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)

Autor: M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 7 (2024)

Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of mark

Externí odkaz: https://doaj.org/article/e6737166623e4811afc3782016a90baa

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy

Autor: I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 16, Iss 1, Pp 51-58 (2020)

Aim. To study the clinical manifestations and factors associated with the presence of chronic heart failure (CHF) in patients with early rheumatoid arthritis (RA) prior to anti-inflammatory therapy. Material and methods. The study included 74 patient

Externí odkaz: https://doaj.org/article/cd015a1b2c0846859d6c58d8500c333c

Calcification of coronary arteries in patients with calcium pyrophosphate crystal deposition disease and knee osteoarthritis

Autor: M. S. Eliseev, D. S. Novikova, A. M. Novikova, L. M. Blank, O. V. Zhelyabina, M. V. Cherkasova, E. L. Nasonov

Publikováno v: Научно-практическая ревматология, Vol 59, Iss 4 (2021)

The frequency of vascular calcification in patients with osteoarthritis (OA) and calcium pyrophosphate crystal deposition disease (CPPD) has not yet been studied, and the role of calcium crystals (basic and pyrophosphates) in the development of calci

Externí odkaz: https://doaj.org/article/a806a72646834685a60f3be5c90ca521

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy

Autor: E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova

Publikováno v: Научно-практическая ревматология, Vol 57, Iss 5, Pp 511-516 (2019)

Patients with psoriatic arthritis (PsA) have a higher risk of cardiovascular disease (CVD) compared with the general population. Inflammation and traditional CVD risk factors (RFs), including dyslipidemia, make a significant contribution to the devel

Externí odkaz: https://doaj.org/article/258a587ff8584e7bac04d81ba3586928

Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment

Autor: E V Gerasimova, T V Popkova, A V Martynova, E I Markelova, D S Novikova, I G Kirillova

Publikováno v: Терапевтический архив, Vol 91, Iss 5, Pp 34-39 (2019)

The high prognostic significance of the concentration of the N-terminal - pro-B-type natriuretic peptide (NT-proBNP) in the development of cardiovascular diseases (CVD) was identified for rheumatoid arthritis (RA) and general populations. Aim: to inv

Externí odkaz: https://doaj.org/article/2f68c4b78ca94cdb8ee4d90ea69f90f6